semaglutide in chronic kidney disease Semaglutide: A Breakthrough for kidney issues with semaglutide Semaglutides

2 These agents are useful against dyskinesia, dystonia, and motor fluctuations, but they carry a higher risk of nonmotor side effects, such as sleepiness, postural hypotension, peripheral edema, and neuropsychiatric issues, compared with levodopa

GHK-Cu vs Traditional Treatments: A Clear Comparison When comparing GHK-Cu to conventional anti-aging methods, the difference comes down to mechanism

Serious concerns with unregulated/high-dose use: infections from non-sterile settings, kidney or liver stress at very high doses over time, and (rarely) thyroid disruption

GLP-1 medicines lower BP in animals and humans, a potential contributing factor to the lowered risk of MACE detected in cardiovascular outcome trials (2)

These approaches give you and your doctor a chance to monitor how your hunger, weight and metabolic markers respond

*** SHOW NOTES [ 00:00 ] Introduction: A Different Kind of GLP-1 Story [ 03:00 ] "Everything Felt Heavy" [ 06:00 ] When Food Became Comfort, Dopamine, and Survival [ 09:00 ] Dieting Young, Without Understanding Why [ 12:00 ] The Discovery That Changed Everything: Obesity Is a Disease [ 15:00 ] Food Noise: What It Really Feels Like [ 15:00 ] "Someone Flipped a Switch" [ 21:00 ] ADHD, Binge Eating, and the Addiction Connection [ 24:00 ] The Early GLP-1 Community and the Stigma They Faced [ 27:00 ] TikTok Bans, Censorship, and Speaking Up Anyway [ 30:00 ] Obesity, Addiction, and Food Noise Exist on a Spectrum [ 33:00 ] A Hyper-Responder to GLP-1s [ 36:00 ] 160 Pounds Lost and a Miracle Pregnancy [ 39:00 ] "It Is Not Your Fault" [ 42:00 ] Oprah, Public Stigma, and Why the Conversation Is Changing *** Get Connected with Elizabeth McGann: Coaching Website: Instagram: Facebook: LinkedIn: X/Twitter: *** Learn more about Rachael Gullette Instagram: Linktree: 44m - Mar 10, 2026 How to Stop GLP-1's Without Gaining the Weight Back (with Dr